Zobrazeno 1 - 10
of 359
pro vyhledávání: '"C. Mettlin"'
Autor:
C. Mettlin
Publikováno v:
European Journal of Cancer. 33:340-347
The purpose of this review is to examine the implications of recent trends in prostate cancer incidence and mortality and to consider recent progress of epidemiological research on this disease. The incidence and mortality rates for prostate cancer a
Autor:
F. K. Mostofi, G. P. Murphy, C. Mettlin, I. A. Sesterhenn, J. G. Batsakis, S. U. Khaliq, V. Nadimpalli, S. Tahan, D. B. Siders, J. Kollin, W. Marsh, M. Owings, J. Sweet
Publikováno v:
The Prostate. 27:7-12
Biopsy materials obtained in the American Cancer Society National Prostate Cancer Detection Project were reviewed at the Central Pathology Laboratory at the Armed Forces Institute of Pathology. Of 265 cases submitted, 177 were diagnosed as prostatic
Autor:
Nachimuthu Natarajan, M. L. Hicks, Trudy R. Baker, M. S. Piver, Ronald E. Hempling, J. M. Thompson, C. Mettlin
Publikováno v:
Journal of Surgical Oncology. 54:38-44
One hundred seventy-one patients with epithelial ovarian cancer were treated on a prospective protocol of weekly cisplatin induction (1 mg/kg weekly for four courses) followed by monthly cisplatin (50 mg/m2), Adriamycin (50 mg/m2), and cyclophosphami
Autor:
John F. Gaeta, Ivana Crogkan, Robert P. Huben, C. Mettlin, Gary A. Croghan, Antonio Lopez-Beltran
Publikováno v:
Cancer. 70:799-807
Clinical and pathologic data of 36 patients with transitional cell carcinoma of the bladder were investigated to determine the significance on patient survival of these factors: pathologic grade and stage; the immunohistochemistry of eight cell and t
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 10(8)
Analgesics have been shown to reduce risk for colorectal cancer. Results from three recent reports (D. W. Cramer et al., Lancet, 351: 104-107, 1998; C. Rodriguez et. al., Lancet, 352: 1354-1355, 1998; L. Rosenberg et al., Cancer Epidemiol. Biomark. P
Publikováno v:
The Prostate. 39(3)
Measurement of the free fraction of total prostate-specific antigen (fPSA%) has been proposed as a useful addition to total PSA for the detection of prostate cancer.We assessed the performance of fPSA% in differentiating men with prostate cancer from
Publikováno v:
The Prostate. 37(4)
There are minimal data on the influence of urinary symptoms and participation in prostate cancer screening in African American men.This correlational study examined the influence of urinary symptoms on 1) participation in a free prostate cancer scree
Publikováno v:
Cancer. 80(6)
Costs and potential benefits of an intensive chest X-ray (CXR) screening program to detect asymptomatic pulmonary metastases in patients with intermediate-thickness, local, cutaneous melanoma were assessed.Cost-effectiveness analysis from a societal
Publikováno v:
Cancer. 78(7)
Previous Commission on Cancer Data from the National Cancer Data Base (NCDB) have examined time trends in stage of disease, treatment patterns, and survival for selected cancers. The most current (1993) data relating to patients with bladder carcinom
Autor:
C, Mettlin, G P, Murphy, R J, Babaian, A, Chesley, R A, Kane, P J, Littrup, F K, Mostofi, P S, Ray, A M, Shanberg, A, Toi
Publikováno v:
Cancer. 77(1)
The American Cancer Society-National Prostate Cancer Detection Project (ACS-NPCDP) is a multidisciplinary evaluation of early prostate cancer detection interventions. This report summarizes the experience of the investigators to date and describes th